Literature DB >> 6437027

Ia antigens: genes, molecules and function.

W P Lafuse, C S David.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6437027     DOI: 10.1097/00007890-198411000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

2.  Reactivity of normal rat epiphyseal chondrocytes with monoclonal antibodies recognizing different leucocyte markers.

Authors:  J Malejczyk; A Romaniuk
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

Authors:  G B McDonald; D P Jewell
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  In vivo inhibition of anti-Thy-1 response by monoclonal antibody to the A molecules of the responder.

Authors:  M B Zaleski; T J Gorzynski; L J Quackenbush; W K Dowjat
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Site recognition by protein-primed T cells shows a non-specific peptide size requirement beyond the essential residues of the site. Demonstration by defining an immunodominant T site in myoglobin.

Authors:  G S Bixler; M Bean; M Z Atassi
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

6.  Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma.

Authors:  Demetrio Tamiolakis; Sylvia Nicolaidou; Sophia Bolioti; Anna Tzilivaki
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

7.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.